SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058229
Filing Date
2023-11-02
Accepted
2023-11-02 16:15:41
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20230930.htm   iXBRL 10-Q 2734532
2 EX-31.1 lbph-ex31_1.htm EX-31.1 20059
3 EX-31.2 lbph-ex31_2.htm EX-31.2 20102
4 EX-32.1 lbph-ex32_1.htm EX-32.1 19659
5 GRAPHIC img9520292_0.jpg GRAPHIC 66473
  Complete submission text file 0000950170-23-058229.txt   11165115

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20230930_lab.xml EX-101.LAB 407916
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20230930_pre.xml EX-101.PRE 305992
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20230930_cal.xml EX-101.CAL 38618
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20230930.xsd EX-101.SCH 45631
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20230930_def.xml EX-101.DEF 165500
55 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20230930_htm.xml XML 2781078
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 231372512
SIC: 2834 Pharmaceutical Preparations